Frederick Nolte to Thalidomide
This is a "connection" page, showing publications Frederick Nolte has written about Thalidomide.
Connection Strength
0.512
-
Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS). Leukemia. 2016 09; 30(9):1956-9.
Score: 0.512